Vasiljević M, Marković A, Ganović R, Jovanović R
Narodni Front Hospital of Gynaecology and Obstetrics, Belgrade.
Srp Arh Celok Lek. 1996 Jul-Aug;124(7-8):193-6.
Pelvic inflammatory diseases are usually caused by sexually transmitted microorganisms, as are Neisseria gonorrhoeae and Chlamydia trachomatis, either alone or associated with endogenous flora of the lower genital tract, as with other gram-positive and gram-negative anaerobic and aerobic bacteria [1, 2].
The aim of the study was to estimate the effect of three broad-spectrum combinations of antimicrobial therapy in the treatment of pelvic inflammatory diseases in hospitalized patients.
We analysed the therapeutic success of some antimicrobial therapies in 154 patients with pelvic inflammatory disease, who were treated in the Narodni Front Hospital of Gynaecology and Obstetrics in Belgrade, during 1992 and 1993. Three drug therapies were applied. The combination of Ceftriaxon plus Doxycycline was given to 51 women. Fifty five women were treated by a combination of Gentamycin plus Clidamycin, and 48 women were treated by a combination of Gentamycin and Metronidazole.
The therapeutic success after the application of the three different antibiotic therapies was recorded in 139 of 154 women (90.26%). Of 136 patients with uncomplicated pelvic inflammatory diseases, the therapeutic success was noted in 129 (94.85%) individuals, while of 18 women with tubo-ovarian abscess therapeutic success was recorded in 10 (55.56%) patients. Of 51 women treated by the combination of Ceftriaxon plus Doxycycline, the therapeutic success was observed in 46 (90.19%) patients. Fifty five women treated by the combination of Gentamycin plus Clindamycin, the therapeutic success was noted in 50 (90.19%) subjects. Of 48 women, treated by the combination of Gentamycin plus Metronidazole, the therapeutic success was found in 43 (89.58%) women. No statistically significant difference was found among the applied antibiotic therapies (p > 0.05). Of 18 women with tubo-ovarian abscess 8 were operated on. Of these 8 women in 6 patients hysterectomy with bilateral salpingo-oophorectomy was performed and in two women unilateral salpingo-oophorectomy was carried out.
Pelvic inflammatory diseases are often of polymicrobial aetiology. In 43 patients we found two types of bacteria in the cervical culture. The therapeutic success was achieved by these three antibiotic therapies. It was 90.26%, the therapeutic success in the treatment of pelvic inflammatory diseases by Ceftriaxon plus Doxycycline was noted in 90.19% of patients. The therapeutic success of antibiotic therapy with Gentamycin plus Clindamycin was obtained in 90.91% of patients. The success of antibiotic therapy with Gentamycin plus Metronidazole was recorded in 89.59% of patients. Our results are similar to those of other authors [3, 4, 6, 7]. No statistically significant difference was found among the applied antibiotic therapies.
An early diagnosis and an aggressive treatment may prevent serious sequelae of this increasingly common sexually transmitted disease. The antibiotics should be of antimicrobial broad spectrum. Good effects can be best reached by a combined antibiotic therapy. Duration of parenteral administration of antibiotics should be several days and for at least 48 hours after the patient's defervescence.
盆腔炎通常由性传播微生物引起,如淋病奈瑟菌和沙眼衣原体,可单独感染,也可与下生殖道的内源性菌群共同感染,其他革兰氏阳性和革兰氏阴性厌氧及需氧菌也可导致感染[1,2]。
本研究旨在评估三种广谱抗菌治疗组合对住院患者盆腔炎的治疗效果。
我们分析了1992年至1993年期间在贝尔格莱德人民阵线妇产科医院接受治疗的154例盆腔炎患者的某些抗菌治疗的疗效。应用了三种药物治疗方案。51名女性接受头孢曲松加强力霉素联合治疗。55名女性接受庆大霉素加克林霉素联合治疗,48名女性接受庆大霉素和甲硝唑联合治疗。
154名女性中有139名(90.26%)在应用三种不同抗生素治疗后取得了治疗成功。在136例无并发症的盆腔炎患者中,129例(94.85%)取得了治疗成功,而在18例输卵管卵巢脓肿患者中,10例(55.56%)取得了治疗成功。在接受头孢曲松加强力霉素联合治疗的51名女性中,46例(90.19%)取得了治疗成功。在接受庆大霉素加克林霉素联合治疗的55名女性中,50例(90.19%)取得了治疗成功。在接受庆大霉素加甲硝唑联合治疗的48名女性中,43例(89.58%)取得了治疗成功。在所应用的抗生素治疗方案之间未发现统计学显著差异(p>0.05)。18例输卵管卵巢脓肿患者中有8例接受了手术。在这8例患者中,6例进行了子宫切除术加双侧输卵管卵巢切除术,2例进行了单侧输卵管卵巢切除术。
盆腔炎通常是多微生物病因。在43例患者的宫颈培养物中我们发现了两种细菌。这三种抗生素治疗取得了治疗成功。成功率为90.26%,头孢曲松加强力霉素治疗盆腔炎的成功率为90.19%。庆大霉素加克林霉素抗生素治疗的成功率为90.91%。庆大霉素加甲硝唑抗生素治疗的成功率为89.59%。我们的结果与其他作者的结果相似[3,4,6,7]。在所应用的抗生素治疗方案之间未发现统计学显著差异。
早期诊断和积极治疗可预防这种日益常见的性传播疾病的严重后遗症。抗生素应具有广谱抗菌性。联合抗生素治疗可达到最佳效果。抗生素的静脉给药时间应为数天,且至少在患者退热后持续48小时。